Related Experiment Videos
Steroid 21-hydroxylase deficiency: genotype may not predict phenotype
R C Wilson1, A B Mercado, K C Cheng
1Department of Pediatrics, New York Hospital-Cornell Medical Center, New York 10021, USA.
The Journal of Clinical Endocrinology and Metabolism
|August 1, 1995
Summary
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency is common. While genotype often predicts phenotype, this study found significant genotype-phenotype discordance in many patients, even within families.
Area of Science:
- Endocrinology
- Genetics
- Pediatric Endocrinology
Background:
- Steroid 21-hydroxylase deficiency is the primary cause of congenital adrenal hyperplasia (CAH).
- Understanding the genotype-phenotype correlation is crucial for managing CAH patients.
Purpose of the Study:
- To investigate the relationship between 21-hydroxylase gene genotype and phenotypic characteristics in a large cohort of CAH patients.
- To assess the predictability of phenotype based on genotype, including within families.
Main Methods:
- Genotyping of the 21-hydroxylase gene in 197 CAH patients.
- Phenotypic assessment including female virilization, ACTH stimulation tests (androgen and 17-hydroxyprogesterone levels), and salt deprivation tests (aldosterone deficiency and salt wasting).
- Analysis of genotype-phenotype concordance across 26 mutation-identical groups.
Main Results:
- A general correlation between genotype severity and phenotype was observed.
- However, significant genotype-phenotype discordance was noted in 13 of the 26 mutation-identical groups.
- The 10 most common 21-hydroxylase gene mutations did not consistently predict patient phenotypes.
Conclusions:
- While genotype often aligns with phenotype in 21-hydroxylase deficiency CAH, exceptions are common.
- Genotype alone may not always accurately predict the clinical presentation or severity of CAH, even in related individuals.
- Further research is needed to understand the factors contributing to genotype-phenotype variability in CAH.